Palisade Capital Management

Palisade Capital Management, LLC is a Fort Lee, NJ based Registered Investment Adviser that manages assets for institutions and high net worth individuals in a variety of product and service offerings. Every day we strive to preserve and enhance wealth by seeking consistent and superior risk-adjusted performance. We believe that anticipation of clients' needs, responsiveness to their requests, and furthering their understanding of our approach is critical to long-term successful relationships.

Alison Berman

President & Chief Executive Officer Co-Chairman, Board of Directors

Jack Feiler

Partner

Wendy S. Popowich

Managing Director of Private Wealth Management

Beata Tannuzzo

MD and CFO

Dennison Theodore Veru

Partner

10 past transactions

ElMindA

Series C in 2015
ElMindA vision is to bring a paradigm change to the management of brain disorders and injuries, by transforming state of the art neuroscience into bed-side clinical practice. ElMindA has developed the BNA™ technology platform, which for the first time allows high resolution visualization and evaluation of the complex neuro-physiological interconnections of the human brain at work, capturing information on the composition, connectivity, synchronization and operation of brain networks.

Brickell Biotech

Series B in 2013
Brickell Biotech, Inc., a Delaware corporation, is a development-stage pharmaceutical company focused on the acquisition, development and commercialization of innovative drug therapies for the treatment of skin diseases.

Neurologix

Venture Round in 2010
Neurologix, Inc., a development stage company, engages in the discovery and development of therapeutic treatments for disorders of the brain and central nervous system. The company's treatments are designed as alternatives to conventional surgical and pharmacological treatments. It primarily focuses on gene therapy for treating Parkinson's disease, a neurodegenerative disorder; and epilepsy, a group of diseases associated with recurrent seizures, which is caused by periodic episodes of repetitive, abnormal electrochemical disturbance in the central nervous system, beginning in the brain. The company also focuses on the development of gene transfers for the treatment of neurodegenerative and metabolic disorders, including Huntington's disease, depression, and metabolic syndrome or genetically-based obesity. Neurologix, Inc. was founded in 1999 and is based in Fort Lee, New Jersey.

Send Word Now

Series D in 2008
Send Word Now is the worldwide provider of enterprise communications services. Their easy-to-use, web-based and mobile solutions are deployed by businesses, government agencies, universities and non-profit organizations to ensure fast, effective communication when it is needed the most. Send Word Now was founded in 2001, by a group of individuals who recognized the need for immediate, reliable and multimodal crisis communications after the tragedies of September 11, 2001. Since that time, organizations across the globe have faced a multitude of natural and man-made disruptions, creating a heightened focus on business continuity, regulatory compliance, security and the ability to audit information flow. Further, today’s borderless business environment and increasingly mobile workforce have surfaced new needs for operations-focused communication and collaboration. Send Word Now is successfully transforming the way organizations communicate globally, both for emergency situations, and for every day, time-sensitive interactions. Their enterprise-class emergency notification system is capable of transmitting tens of thousands of voice and text messages in minutes, while providing a full audit trail for after action reporting and follow-up. Their mobile conferencing, collaboration and workflow solutions keep employees informed and connected to the people and information they need. And, everything is backed by their 100% Uptime reliability guarantee, and unmatched 24x7x365 customer support. In emergencies, or every day. When rapid, effective communication is essential for success, rely on Send Word Now for innovative, secure and reliable notification and collaboration solutions.

Mitralign

Series C in 2007
Mitralign is a venture backed privately held company located in a suburb of Boston, MA. The company is developing an innovative catheter based technology for percutaneous treatment of functional mitral regurgitation. The novel Mitralign system emulates surgical annuloplasty as it delivers a series of surgical implants directly into the mitral annulus by means of a catheter. The implants are cinched together, thus reducing the size of the mitral valve annulus and the valve opening. Mitralign is funded by top tier venture capitalists and has two major cardiovascular device companies as investors.

Shoe Sensation

Private Equity Round in 2007
Shoe Sensation, Inc. operates a regional chain of shoe stores across several states, including Arkansas, Illinois, Indiana, Iowa, Kentucky, Michigan, Minnesota, Missouri, Ohio, Pennsylvania, Tennessee, and West Virginia. Founded in 1974 and based in Jeffersonville, Indiana, the company specializes in providing a wide selection of quality name-brand footwear for men, women, and children, including athletic options. Shoe Sensation aims to meet the diverse footwear needs of families, catering to customers from toddlers to seniors. The stores focus on offering a better-branded merchandise mix to enhance the shopping experience.

Ikonisys

Series E in 2007
Ikonisys, Inc. specializes in designing and manufacturing medical diagnostic products aimed at cancer diagnosis and genetic disorder detection in the United States and Europe. The company offers a range of innovative products, including the Ikoniscope Robotic Microscope, which automates slide handling, scanning, and real-time image analysis to minimize human error in testing. Key applications include oncoFISH bladder for analyzing urine samples, oncoFISH her2 for assessing HER2 status in breast tissue, and oncoFISH PTEN for detecting PTEN gene deletions in prostate biopsies. Additionally, Ikonisys provides FISH scanning applications for both cell suspensions and various tissue sections, along with the IkoniWAN Gateway, a remote access solution for digital microscopy systems. Founded in 1999 and headquartered in New Haven, Connecticut, Ikonisys is committed to advancing diagnostic medicine through early and non-invasive disease detection, thereby enhancing patient management.

Language Weaver

Series B in 2004
Language Weaver, Inc. specializes in developing and licensing automated translation solutions tailored for multinationals, government organizations, and translation providers. The company offers a range of products, including the LW Enterprise Translation Server, an on-site software designed for language translation within enterprises. Additionally, it provides the LW Custom Enterprise Translation Server, which focuses on domain-specific translations across various industries such as information technology, automotive, medical, and finance. For immediate translation needs, Language Weaver offers LW Translation On Demand, along with a dedicated server option through LW Custom Translation On Demand. The company also provides professional services, including software training, custom language pair development, and the preparation of parallel data, ensuring comprehensive support for its clients' translation requirements.

Achieve3000

Series B in 2004
Achieve3000 delivers differentiated literacy solutions proven to increase reading comprehension and fluency, vocabulary and writing proficiency for students in grades 2 through 12. Through its proprietary software engine, the company uses the Internet to provide each student with an appropriate version of the same content based on his or her reading level. The company's products include KidBiz3000 (a reading and writing program for grades 2 through 5), TeenBiz3000 (a reading and writing program for grades 6 through 12) and Spark3000® (a reading and writing program for adult learners).

Versura

Venture Round in 2001
Versura is a business-to-business exchange dedicated to expanding opportunities for participants in the higher education finance industry. For educational institutions, Versura offers an Internet-based service that streamlines the preferred lender selection process. With Versura, schools can customize a loan program to get the best value for their institutions and students. For lenders and financial institutions, Versura offers an open digital marketplace that expands market opportunities. Through Versura, lenders can connect with colleges and universities all over the country and loan sellers can connect with buyers interested in all or part of their loan portfolio.